WebDisclosure WebDisclosure
Basculer en Français
10964 Companies
239970 Keywords
168738 Articles
129110 Press releases
Headlines Articles Press releases IMed Medical Remove
  1. Home
  2. Companies
  3. IMed Medical
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/28/2024 at 10:02, 2 years 6 months ago

    La Turquie, Un Nouveau Hub du Tourisme de Santé à Prix Accessibles

    Tourisme De Santé IMed Medical Soins Médicaux Abordables Esthétique Naturelle Turquie
  • BRIEF

    published on 02/28/2024 at 10:02, 2 years 6 months ago

    Turkey, A New Hub for Health Tourism at Accessible Prices

    Health Tourism IMed Medical Affordable Medical Care Natural Aesthetics Türkiye
  • PRESS RELEASE

    published on 02/28/2024 at 10:02, 2 years 6 months ago

    iMed Medical: “Tourists visiting Türkiye integrate their treatments with Istanbul vacations”

    iMed Medical, an Istanbul-based health tourism agency offers tailor-made services like a personal assistant for health tourists, providing state-of-the-art technology systems and affordable treatments. Turkey's health tourism revenues forecasted to grow by 6.6% according to a report by Future Market Insights
    Istanbul Health Tourism State-of-the-art Technology Affordable Treatments Future Market Insights
    Logo of IMed Medical
Accesswire
  • Published on 09/11/2026 at 04:00, 3 hours 10 minutes ago

    Torq Announces Debt Settlement and Corporate Update

  • Published on 09/10/2026 at 22:25, 8 hours 45 minutes ago

    Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer

  • Published on 09/10/2026 at 17:46, 13 hours 24 minutes ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 15 hours 50 minutes ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 16 hours 10 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 00:05, 7 hours 4 minutes ago

    Club Offers for Travel Enthusiasts in Germany

  • Published on 09/11/2026 at 00:01, 7 hours 9 minutes ago

    Club Offers for Travel Enthusiasts in Germany

  • Published on 09/10/2026 at 22:39, 8 hours 30 minutes ago

    EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law

  • Published on 09/10/2026 at 22:10, 8 hours 59 minutes ago

    flatexDEGIRO with changes to the Supervisory Board

  • Published on 09/10/2026 at 22:07, 9 hours 3 minutes ago

    EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 10 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 10 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 10 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 10 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 11 hours 40 minutes ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy